# ABC-06 (NCT01926236)

> Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers

No report yet. It can be ordered.

- Drugs tested: FOLFOX
- Indication: second-line advanced biliary tract cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01926236
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: The Christie NHS Foundation Trust
- Conditions: Biliary Tract Cancer; Gallbladder Cancer; Cholangiocarcinoma; Ampullary Cancer
- Interventions: Active Symptom Control; L-folinic acid; 5 FU; Oxaliplatin
- Enrollment: 162
- Primary outcome: Overall survival

## Indexed commentary on ABC-06 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 17
- YouTube: 16
- Podcasts: 11

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=abc-06-nct01926236

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01926236", "email": "<work email>"}; the inbox owner confirms by the emailed link.